Home
VERO Biotech

VERO Biotech Market Share Analysis for June 2026

Our commitment is innovation in the life sciences space. See how GENOSYL DS epitomizes that commitment.

Industry: N/A

Domainvero-biotech.com

Year Founded2006

Employees201 - 500

Annual Revenue$15M - $25M

VERO Biotech

VERO Biotech (including company regionals)

vero-biotech.com

See more website traffic and engagement information

VERO Biotech Revenue up to June 2026 is 15M - 25M

revenue generated by VERO Biotech top domains

VERO Biotech top domains revenue over 3 years

Revenue for VERO Biotech top domains

vero-biotech.com15M - 25M

See more with Sales Intelligence

Total visits to VERO Biotech's top domains

Understand VERO Biotech market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

vero-biotech.com5.7K

See more with Sales Intelligence

Avg. visit duration in VERO Biotech's top domains

Analyze VERO Biotech engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

vero-biotech.com00:04:04

See more with Sales Intelligence

Avg. pageviews on VERO Biotech's top domains

See how VERO Biotech keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

vero-biotech.com4.30

See more with Sales Intelligence

VERO Biotech top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by VERO Biotech

These are the website technologies, by industry, used by VERO Biotech top domains

Widget (5)

Twemoji

Social (4)

Instagram

Content Management System (3)

WordPress

Advertising (2)

DoubleClick

More Technologies

11

See all

News & Signals from VERO Biotech

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVero Biotech LLC hires Suzanne Hagin as VP of Strategic Development.VERO welcomes Suzanne Hagin as VP of Commercial Operations & Marketing and Rebecca Van Doren as VP of Strategic Development

NewsVero Biotech LLC launched Genosyl DS on Feb 11th '24.Most recently, he served as Senior Vice President of Commercialization at Vero Biotech launching the first tankless inhaled nitric oxide system, Genosyl(R) DS.

NewsVero Biotech LLC launched GENOSYL Inhaled Nitric Oxide delivery system generation on Feb 2nd '23.VERO Biotech Inc., a commercial-stage healthcare business dedicated to neonatal intensive care and the acute care hospital community, today announced FDA approval of its innovative second generation GENOSYL® Inhaled Nitric Oxide (iNO) delivery system for use with rebreathing anesthesia in the operating room setting.